Ira Scott Greenspan is Chairman & 10% at Scopus BioPharma Inc. (SCPS). They have made 11 open-market trades across 2 companies since 2018, most recently 2021-08-27.
CIK 0001449211
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $122K since 2021, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCPS | BUY | 2021-08-27 | 2021-08-30 | $4.97 | $4K | N/A | N/A | N/A |
| SCPS | BUY | 2021-08-23 | 2021-08-25 | $4.43 | $2K | N/A | N/A | N/A |
| SCPS | BUY | 2021-08-19 | 2021-08-23 | $4.07 | $10K | N/A | N/A | N/A |
| SCPS | BUY | 2021-08-17 | 2021-08-19 | $4.20 | $8K | N/A | N/A | N/A |
| SCPS | BUY | 2021-07-23 | 2021-07-27 | $4.76 | $13K | N/A | N/A | N/A |
| SCPS | BUY | 2021-02-24 | 2021-02-26 | $9.16 | $11K | N/A | N/A | N/A |
| SCPS | BUY | 2021-02-23 | 2021-02-24 | $9.65 | $14K | N/A | N/A | N/A |
| SCPS | BUY | 2021-02-22 | 2021-02-23 | $10.05 | $5K | N/A | N/A | N/A |
| SCPS | BUY | 2021-02-16 | 2021-02-18 | $10.07 | $54K | N/A | N/A | N/A |
| PAVM | SELL | 2018-06-08 | 2018-06-11 | $1.04 | $19K | -4.9% | +24.8% | +39.6% |
| PAVM | SELL | 2018-06-01 | 2018-06-05 | $0.97 | $1.0M | -2.9% | +11.0% | +31.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.